TOL-463

a boric acid and EDTA-based anti-infective agent for the treatment of bacterial vaginosis and vulvovaginal candidiasis

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

1.	Dithmer, Dwyn: 1 article (01/2019)
2.	Dombrowski, Julia C: 1 article (01/2019)
3.	Marrazzo, Jeanne M: 1 article (01/2019)
4.	Perlowski, Charlotte: 1 article (01/2019)
5.	Pontius, Angela: 1 article (01/2019)
6.	Schwebke, Jane: 1 article (01/2019)
7.	Wierzbicki, Michael R: 1 article (01/2019)

1.	Bacterial Vaginosis 01/01/2019 - "Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial."
2.	Vulvovaginal Candidiasis 01/01/2019 - "Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial."